Search Results for: Marc Tessier-Lavigne
Medical innovation requires federal support and structural improvements, Marc Tessier-Lavigne tells members of Congress
Speaking at a hearing on public versus private contributions to medical breakthroughs, Rockefeller’s president explained the ecosystem responsible for taking a biological insight on, for example, how tumors spread, and turning it into a treatment that improves or saves lives. He also offered suggestions for how the federal government could further encourage such breakthroughs.
Tessier-Lavigne, Rockefeller president and head of the Laboratory of Brain Development, and Jeffrey M. Friedman head of the Laboratory of Molecular Genetics, were elected to the honorary society and independent policy research center along with 198 other leaders in science, art, academia and the civic, corporate and philanthropic arenas. The current membership includes some 250 Nobel laureates and more than 60 Pulitzer Prize winners, and 23 other Rockefeller University faculty members are fellows.
President Marc Tessier-Lavigne will receive the Henry G. Friesen International Prize in Health Research, established by the Friends of Canadian Institutes of Health Research in collaboration with the Canadian Academy of Health Sciences to recognize exceptional innovation by a visionary health leader of international stature.
A world leader in the study of brain development, Tessier-Lavigne has pioneered the identification of the molecules that direct the formation of connections among nerve cells to establish neuronal circuits in the mammalian brain and spinal cord. Tessier-Lavigne is among 65 new members and five foreign associates elected to the Institute this year. More »
Rockefeller University’s President will receive the Memorial Sloan-Kettering Medal for Outstanding Contributions to Biomedical Research at MSKCC’s 2011 Academic Convocation. More »
Marc Tessier-Lavigne, a leading neuroscientist and the former chief scientific officer of Genentech, takes over as president of The Rockefeller University today, replacing Paul Nurse, who has left to become president of the Royal Society in London. More »
The university’s Board of Trustees has elected Tessier-Lavigne to succeed Paul Nurse on March 11, 2011. A leader in the study of brain development, he is currently executive vice president for research and chief scientific officer at Genentech, one the world’s leading biotech companies. More »
The award recognizes Fuchs’s contributions to our understanding of skin biology and skin stem cells, including discoveries that have led to advancements in treating skin cancer and severe burns.
Joseph Gleeson, a neurogeneticist, has left the University of California, San Diego, to establish his lab at Rockefeller, where he will continue hunting down the single-gene mutations responsible for an array of neurodevelopmental disorders. More »
Jue Chen, currently a tenured professor of biology at Purdue University in Indiana and Howard Hughes Medical Institute investigator, studies transporter proteins that act as the cell’s pumping machinery, and their role in health and disease. More »
New structural images help explain how young neurons make the right connections, showing how a signal, Netrin-1, interacts with specific receptors that tell neurons in which direction to reach.
Science online: May 29, 2014 Structures of netrin-1 bound to two receptors provide insight into its axon guidance mechanism Kai Xu, Zhuhao Wu, Nicolas Renier, Alexander Antipenko, Dorothea Tzvetkova-Robev, Yan Xu, Maria Minchenko, Vincenzo Nardi-Dei, Kanagalaghatta R. Rajashankar, Juha Himanen, … More »
The Rockefeller University has the highest percentage of frequently cited scientific publications of 750 top universities worldwide, according to ranking created by the Center for Science and Technology Studies of Leiden University in The Netherlands. More »
The building, first envisioned over two years ago and known as the River Building, will house bioscience laboratories, and will serve as a replacement for existing lab facilities that are reaching the end of their operational life and are no longer suitable for modern science. More »
Darnell, who focuses on understanding a group of rare brain diseases, the paraneoplastic neurologic disorders (PNDs), and how they arise in conjunction with immune responses to cancer, is one of 84 newly elected members announced today by the Academy.
de Lange is being recognized for her discovery of the mechanisms by which mammalian telomeres are protected from deleterious DNA repair and damage responses. The Gairdner is Canada’s highest scientific award and is considered among the most prestigious international prizes in science. More »
Current Biology 24: 494-508 FLRT3 is a robo1-interacting protein that determines netrin-1 attraction in developing axons Eduardo Leyva-Díaz, Daniel del Toro, Maria José Menal, Serafi Cambray, Rafael Susín, Marc Tessier-Lavigne, Rüdiger Klein, Joaquim Egea and Guillermina López-Bendito
Allis’s discovery that chemical “tags” bind to specific sections of histone proteins in order to activate or silence nearby genes has ignited the field of epigenetics, a relatively new area of study which explores the inheritance of physical changes that cannot be traced back to mutations in the DNA sequence. The Japan Prize, worth approximately half a million dollars, is among the most prestigious prizes in science. More »
The fund, to be known as the Robertson Therapeutic Development Fund in honor of a $25 million gift from the Robertson Foundation, will provide Rockefeller scientists with resources required to take exceptionally promising basic research initiatives through the steps that lead to breakthrough medications, new diagnostic tests or other clinical innovations. More »